Auto - Dealerships
Compare Stocks
5 / 10Stock Comparison
CANG vs AUTL vs CAAS vs BIDU vs NIO
Revenue, margins, valuation, and 5-year total return — side by side.
Biotechnology
Auto - Parts
Internet Content & Information
Auto - Manufacturers
CANG vs AUTL vs CAAS vs BIDU vs NIO — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Auto - Dealerships | Biotechnology | Auto - Parts | Internet Content & Information | Auto - Manufacturers |
| Market Cap | $250M | $410M | $137M | $48.92B | $12.28B |
| Revenue (TTM) | $3.46B | $51M | $696M | $130.46B | $69.42B |
| Net Income (TTM) | $-178M | $-225M | $29M | $9.00B | $-24.31B |
| Gross Margin | 13.6% | -309.4% | 16.5% | 44.7% | 10.3% |
| Operating Margin | 7.3% | -8.6% | 5.9% | -2.6% | -32.6% |
| Forward P/E | 5.7x | — | 7.1x | 2.6x | — |
| Total Debt | $170M | $53M | $209M | $79.32B | $33.82B |
| Cash & Equiv. | $1.29B | $227M | $142M | $24.83B | $19.33B |
CANG vs AUTL vs CAAS vs BIDU vs NIO — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Cango Inc. (CANG) | 100 | 22.4 | -77.6% |
| Autolus Therapeutic… (AUTL) | 100 | 12.8 | -87.2% |
| China Automotive Sy… (CAAS) | 100 | 234.0 | +134.0% |
| Baidu, Inc. (BIDU) | 100 | 131.3 | +31.3% |
| NIO Inc. (NIO) | 100 | 147.5 | +47.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CANG vs AUTL vs CAAS vs BIDU vs NIO
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CANG lags the leaders in this set but could rank higher in a more targeted comparison.
AUTL ranks third and is worth considering specifically for growth exposure.
- Rev growth 496.0%, EPS growth 27.5%, 3Y rev CAGR 88.7%
- 496.0% revenue growth vs CANG's -52.7%
CAAS carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- Dividend streak 0 yrs, beta 0.42, yield 1.6%
- 35.2% 10Y total return vs BIDU's -17.5%
- Lower volatility, beta 0.42, Low D/E 46.5%, current ratio 1.36x
- Beta 0.42, yield 1.6%, current ratio 1.36x
BIDU is the #2 pick in this set and the best alternative if value and quality is your priority.
- Better valuation composite
- 6.9% margin vs AUTL's -439.7%
- +61.3% vs CANG's -73.7%
Among these 5 stocks, NIO doesn't own a clear edge in any measured category.
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 496.0% revenue growth vs CANG's -52.7% | |
| Value | Better valuation composite | |
| Quality / Margins | 6.9% margin vs AUTL's -439.7% | |
| Stability / Safety | Beta 0.42 vs CANG's 2.25 | |
| Dividends | 1.6% yield; the other 4 pay no meaningful dividend | |
| Momentum (1Y) | +61.3% vs CANG's -73.7% | |
| Efficiency (ROA) | 3.5% ROA vs AUTL's -34.0%, ROIC 8.8% vs -204.1% |
CANG vs AUTL vs CAAS vs BIDU vs NIO — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
CANG vs AUTL vs CAAS vs BIDU vs NIO — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
CAAS leads in 4 of 6 categories
CANG leads 2 • AUTL leads 0 • BIDU leads 0 • NIO leads 0
Explore the data ↓Income & Cash Flow (Last 12 Months)
CANG leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
BIDU is the larger business by revenue, generating $130.5B annually — 2551.7x AUTL's $51M. BIDU is the more profitable business, keeping 6.9% of every revenue dollar as net income compared to AUTL's -4.4%. On growth, CANG holds the edge at +58.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $3.5B | $51M | $696M | $130.5B | $69.4B |
| EBITDAEarnings before interest/tax | $333M | -$427M | $60M | $4.9B | -$23.0B |
| Net IncomeAfter-tax profit | -$178M | -$225M | $29M | $9.0B | -$24.3B |
| Free Cash FlowCash after capex | $0 | -$278M | -$3M | -$15.7B | -$16.5B |
| Gross MarginGross profit ÷ Revenue | +13.6% | -3.1% | +16.5% | +44.7% | +10.3% |
| Operating MarginEBIT ÷ Revenue | +7.3% | -8.6% | +5.9% | -2.6% | -32.6% |
| Net MarginNet income ÷ Revenue | -5.2% | -4.4% | +4.2% | +6.9% | -35.0% |
| FCF MarginFCF ÷ Revenue | -154.0% | -5.4% | -0.4% | -12.0% | -23.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | +58.3% | — | +11.1% | -7.1% | +9.0% |
| EPS Growth (YoY)Latest quarter vs prior year | +3.6% | +3.2% | +4.2% | -2.6% | +7.6% |
Valuation Metrics
CAAS leads this category, winning 4 of 6 comparable metrics.
Valuation Metrics
At 3.2x trailing earnings, CAAS trades at a 78% valuation discount to BIDU's 14.4x P/E. On an enterprise value basis, CAAS's 2.8x EV/EBITDA is more attractive than BIDU's 10.8x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $250M | $410M | $137M | $48.9B | $12.3B |
| Enterprise ValueMkt cap + debt − cash | $85M | $235M | $204M | $56.9B | $14.4B |
| Trailing P/EPrice ÷ TTM EPS | 5.66x | -1.84x | 3.20x | 14.44x | -3.62x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — | 7.09x | 2.58x | — |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | 0.24x | — |
| EV / EBITDAEnterprise value multiple | 3.13x | — | 2.77x | 10.79x | — |
| Price / SalesMarket cap ÷ Revenue | 2.12x | 40.47x | 0.18x | 2.50x | 1.27x |
| Price / BookPrice ÷ Book value/share | 0.42x | 0.96x | 0.30x | 1.17x | 6.08x |
| Price / FCFMarket cap ÷ FCF | — | — | 1.92x | 25.41x | — |
Profitability & Efficiency
CAAS leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
CAAS delivers a 7.4% return on equity — every $100 of shareholder capital generates $7 in annual profit, vs $-3 for NIO. CANG carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to NIO's 2.50x. On the Piotroski fundamental quality scale (0–9), CAAS scores 7/9 vs NIO's 3/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -4.1% | -84.7% | +7.4% | +3.1% | -2.7% |
| ROA (TTM)Return on assets | -2.3% | -34.0% | +3.5% | +2.0% | -23.7% |
| ROICReturn on invested capital | +4.6% | -2.0% | +8.8% | +4.8% | -55.2% |
| ROCEReturn on capital employed | +4.5% | -45.9% | +13.9% | +6.3% | -41.7% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 5 | 7 | 5 | 3 |
| Debt / EquityFinancial leverage | 0.04x | 0.12x | 0.46x | 0.28x | 2.50x |
| Net DebtTotal debt minus cash | -$1.1B | -$175M | $67M | $54.5B | $14.5B |
| Cash & Equiv.Liquid assets | $1.3B | $227M | $142M | $24.8B | $19.3B |
| Total DebtShort + long-term debt | $170M | $53M | $209M | $79.3B | $33.8B |
| Interest CoverageEBIT ÷ Interest expense | -1.87x | -25.98x | 22.18x | 9.71x | -25.29x |
Total Returns (Dividends Reinvested)
CAAS leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CAAS five years ago would be worth $12,333 today (with dividends reinvested), compared to $1,589 for NIO. Over the past 12 months, BIDU leads with a +61.3% total return vs CANG's -73.7%. The 3-year compound annual growth rate (CAGR) favors CAAS at 7.2% vs NIO's -10.8% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -62.0% | -14.2% | +5.3% | -6.9% | +14.2% |
| 1-Year ReturnPast 12 months | -73.7% | +30.5% | +12.7% | +61.3% | +52.9% |
| 3-Year ReturnCumulative with dividends | +1.2% | -14.6% | +23.0% | +14.2% | -29.0% |
| 5-Year ReturnCumulative with dividends | -14.2% | -70.1% | +23.3% | -27.0% | -84.1% |
| 10-Year ReturnCumulative with dividends | -44.9% | -93.6% | +35.2% | -17.5% | -11.1% |
| CAGR (3Y)Annualised 3-year return | +0.4% | -5.1% | +7.2% | +4.5% | -10.8% |
Risk & Volatility
CAAS leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
CAAS is the less volatile stock with a 0.42 beta — it tends to amplify market swings less than CANG's 2.25 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CAAS currently trades 88.2% from its 52-week high vs CANG's 18.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 2.25x | 1.95x | 0.42x | 1.41x | 1.29x |
| 52-Week HighHighest price in past year | $2.88 | $2.70 | $5.15 | $165.30 | $8.02 |
| 52-Week LowLowest price in past year | $0.33 | $1.15 | $3.84 | $81.17 | $3.34 |
| % of 52W HighCurrent price vs 52-week peak | +18.6% | +59.4% | +88.2% | +84.6% | +73.2% |
| RSI (14)Momentum oscillator 0–100 | 58.6 | 64.3 | 63.2 | 69.1 | 44.3 |
| Avg Volume (50D)Average daily shares traded | 1.3M | 1.6M | 29K | 2.0M | 39.7M |
Analyst Outlook
CANG leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: CANG as "Buy", AUTL as "Buy", BIDU as "Buy", NIO as "Buy". Consensus price targets imply 459.2% upside for CANG (target: $3) vs 9.9% for NIO (target: $6). CAAS is the only dividend payer here at 1.60% yield — a key consideration for income-focused portfolios.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | — | Buy | Buy |
| Price TargetConsensus 12-month target | $3.00 | $8.87 | — | $154.70 | $6.45 |
| # AnalystsCovering analysts | 2 | 14 | — | 53 | 24 |
| Dividend YieldAnnual dividend ÷ price | — | — | +1.6% | — | — |
| Dividend StreakConsecutive years of raises | 5 | — | 0 | 3 | — |
| Dividend / ShareAnnual DPS | — | — | $0.07 | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +5.3% | 0.0% | 0.0% | +1.9% | 0.0% |
CAAS leads in 4 of 6 categories (Valuation Metrics, Profitability & Efficiency). CANG leads in 2 (Income & Cash Flow, Analyst Outlook).
CANG vs AUTL vs CAAS vs BIDU vs NIO: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is CANG or AUTL or CAAS or BIDU or NIO a better buy right now?
For growth investors, Autolus Therapeutics plc (AUTL) is the stronger pick with 496.
0% revenue growth year-over-year, versus -52. 7% for Cango Inc. (CANG). China Automotive Systems, Inc. (CAAS) offers the better valuation at 3. 2x trailing P/E (7. 1x forward), making it the more compelling value choice. Analysts rate Cango Inc. (CANG) a "Buy" — based on 2 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CANG or AUTL or CAAS or BIDU or NIO?
On trailing P/E, China Automotive Systems, Inc.
(CAAS) is the cheapest at 3. 2x versus Baidu, Inc. at 14. 4x. On forward P/E, Baidu, Inc. is actually cheaper at 2. 6x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — CANG or AUTL or CAAS or BIDU or NIO?
Over the past 5 years, China Automotive Systems, Inc.
(CAAS) delivered a total return of +23. 3%, compared to -84. 1% for NIO Inc. (NIO). Over 10 years, the gap is even starker: CAAS returned +35. 2% versus AUTL's -93. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CANG or AUTL or CAAS or BIDU or NIO?
By beta (market sensitivity over 5 years), China Automotive Systems, Inc.
(CAAS) is the lower-risk stock at 0. 42β versus Cango Inc. 's 2. 25β — meaning CANG is approximately 442% more volatile than CAAS relative to the S&P 500. On balance sheet safety, Cango Inc. (CANG) carries a lower debt/equity ratio of 4% versus 3% for NIO Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — CANG or AUTL or CAAS or BIDU or NIO?
By revenue growth (latest reported year), Autolus Therapeutics plc (AUTL) is pulling ahead at 496.
0% versus -52. 7% for Cango Inc. (CANG). On earnings-per-share growth, the picture is similar: Cango Inc. grew EPS 960. 0% year-over-year, compared to 11. 3% for NIO Inc.. Over a 3-year CAGR, AUTL leads at 88. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CANG or AUTL or CAAS or BIDU or NIO?
Cango Inc.
(CANG) is the more profitable company, earning 37. 3% net margin versus -21. 8% for Autolus Therapeutics plc — meaning it keeps 37. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CANG leads at 22. 2% versus -23. 9% for AUTL. At the gross margin level — before operating expenses — CANG leads at 55. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CANG or AUTL or CAAS or BIDU or NIO more undervalued right now?
On forward earnings alone, Baidu, Inc.
(BIDU) trades at 2. 6x forward P/E versus 7. 1x for China Automotive Systems, Inc. — 4. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CANG: 459. 2% to $3. 00.
08Which pays a better dividend — CANG or AUTL or CAAS or BIDU or NIO?
In this comparison, CAAS (1.
6% yield) pays a dividend. CANG, AUTL, BIDU, NIO do not pay a meaningful dividend and should not be held primarily for income.
09Is CANG or AUTL or CAAS or BIDU or NIO better for a retirement portfolio?
For long-horizon retirement investors, China Automotive Systems, Inc.
(CAAS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 42), 1. 6% yield). Cango Inc. (CANG) carries a higher beta of 2. 25 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (CAAS: +35. 2%, CANG: -44. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CANG and AUTL and CAAS and BIDU and NIO?
These companies operate in different sectors (CANG (Consumer Cyclical) and AUTL (Healthcare) and CAAS (Consumer Cyclical) and BIDU (Communication Services) and NIO (Consumer Cyclical)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: CANG is a small-cap deep-value stock; AUTL is a small-cap high-growth stock; CAAS is a small-cap high-growth stock; BIDU is a mid-cap deep-value stock; NIO is a mid-cap high-growth stock. CAAS pays a dividend while CANG, AUTL, BIDU, NIO do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.